MCRB – seres therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT [Yahoo! Finance]
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Global Microbiome Manufacturing Industry Research 2024: A $187 Billion Market by 2035 with Close to 170 Trials Evaluating Microbiome Therapeutics to Treat Infectious Diseases and Oncological Disorders [Yahoo! Finance]
Increases to Seres Therapeutics, Inc.'s (NASDAQ:MCRB) CEO Compensation Might Cool off for now [Yahoo! Finance]
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form 8-K Seres Therapeutics, Inc. For: Apr 19
Form 4 Seres Therapeutics, Inc. For: Apr 04 Filed by: Biondi Paul
Form 4 Seres Therapeutics, Inc. For: Apr 04 Filed by: Ausiello Dennis A
Form 4 Seres Therapeutics, Inc. For: Apr 04 Filed by: Graves Kurt
Form 4 Seres Therapeutics, Inc. For: Apr 04 Filed by: Fraser Claire
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.